Ten-year Change in Vision-related Quality of Life in Type 1 Diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy
Overview
Affiliations
Purpose: To investigate changes of vision-related quality of life during a 10-year period in a population with type 1 diabetes.
Design: Prospective cohort study.
Participants: Individuals who had their diabetes diagnosed before 30 years of age were considered to have type 1 diabetes (N = 1210). Those who participated in both 14-year (1995-1996) and 25-year (2005-2007) follow-up examinations were included in the current analysis (N = 471).
Methods: Vision-related quality of life was measured with the National Eye Institute Visual Function Questionnaire (NEI-VFQ-25).
Main Outcome Measures: Changes in vision-related quality of life scores.
Results: Loss of 3 lines in the Early Treatment Diabetic Retinopathy Study (ETDRS) chart was the most important factor related to negative changes in the NEI-VFQ-25 scores in our study after controlling for confounders. Most important changes were observed in subscales, such as general vision (-6.46 points), mental health (-10.19 points), role difficulty (-6.90 points), and driving (-10.43 points). Unemployment and the development of long-term complications, such as nephropathy, were also associated with negative changes in some NEI-VFQ-25 subscale scores. However, changes in diabetic retinopathy status were not related to changes in any subscale after 10 years.
Conclusions: Change in visual acuity was the most important factor associated with changes in vision-related quality of life scores in individuals with type 1 diabetes during a 10-year period. Our findings support the necessity of close follow-up of individuals with type 1 diabetes to avoid development of long-term complications and vision loss to improve quality of life.
Shrateh O, Abdelhafez M, Ereqat S, Dein L, Iriqat S Endocrinol Diabetes Metab. 2024; 7(4):e494.
PMID: 38874277 PMC: 11177287. DOI: 10.1002/edm2.494.
Trott M, Driscoll R, Pardhan S BMC Endocr Disord. 2022; 22(1):311.
PMID: 36494641 PMC: 9733253. DOI: 10.1186/s12902-022-01236-8.
Micro (mi) RNA and Diabetic Retinopathy.
Sadashiv , Sharma P, Dwivedi S, Tiwari S, Singh P, Pal A Indian J Clin Biochem. 2022; 37(3):267-274.
PMID: 35873619 PMC: 9300788. DOI: 10.1007/s12291-021-01018-4.
Trott M, Driscoll R, Iraldo E, Pardhan S J Diabetes Metab Disord. 2022; 21(1):1047-1054.
PMID: 35673454 PMC: 9167365. DOI: 10.1007/s40200-022-00980-x.
Trott M, Driscoll R, Iraldo E, Pardhan S J Diabetes Metab Disord. 2022; 21(1):1177-1184.
PMID: 35673423 PMC: 9167360. DOI: 10.1007/s40200-022-01059-3.